PRMT5 and breast carcinoma: We observed a positive correlation between MEP50 and PRMT5 mRNA levels in our cohort in the whole breast cancer population but not within the different breast cancer subgroups, although a tendency was observed for the luminal B subgroup (p = 0.053) (Figure S1).